$HCM $AZN Saffron study makes no sense to me. Why would you give a small-molecule cMet inhibitor to patients who happen to have cMet w/t amplification, but whose tumour is still dr

Jacob Plieth· @JacobPlieth · X·2026-10-26 00:20· 1 天前评分70

正文 · 原文

$HCM $AZN Saffron study makes no sense to me. Why would you give a small-molecule cMet inhibitor to patients who happen to have cMet w/t amplification, but whose tumour is still driven by EGFRm? #Esmo26

500 浏览 · 0 赞 · 0 转发 · 0 回复

来源：Jacob Plieth · x.com